Evidence map›Paper›PMID 9122206›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

Molecular characterization of Br-cadherin, a developmentally regulated, brain-specific cadherin.

S Selig, H G Lidov, S A Bruno, M M Segal, L M Kunkel

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S SeligDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
H G Lidov
S A Bruno
M M Segal
L M Kunkel
Harvard University · USHoward Hughes Medical Institute · US

Funding

CLONING OF A 120 KD OLFACTORY DYSTROPHIN TRANSCRIPTK08NS001739 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI LIDOV, HART G · 1994 to 1998
–
X-LINKED MENTAL RETARDATION AND X-CHROMOSOME ABNORMALITIESP01HD018658 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI KUNKEL, LOUIS M · 1985 to 1997
–
NICHD NIH HHS HD18658NINDS NIH HHS KO8NS01739-01
6 · The paper itself

Abstract

Cadherins are a family of transmembrane proteins that play a crucial role in cell adhesion and in morphogenesis. Several of the cadherins are expressed in the nervous system, but none is neuron-specific. We characterize a new member of the cadherin family, Br-cadherin, which is present exclusively in the central nervous system. Although the Br-cadherin protein is confined to the central nervous system, its mRNA is present in several additional tissues, suggesting that there is posttranscriptional control of this gene's expression. Within the central nervous system, Br-cadherin appears to be expressed specifically by neurons. In the mouse, its expression becomes detectable during the first postnatal week, which corresponds temporally to the onset of synaptogenesis and dendrite outgrowth in the brain. This pattern of expression is consistent with a role for Br-cadherin in neuronal development, perhaps specifically with synaptogenesis.

Indexed as

Gene Expression Regulation, DevelopmentalTranscription, GeneticAgingAmino Acid SequenceAnimalsAnimals, NewbornAntibodiesBrainCadherinsExonsGestational AgeHumansIntronsMiceMice, Inbred C57BLMolecular Sequence DataAntibodiesCadherinsPeptide FragmentsRNA, Messenger

Identifiers

PMID9122206
PMCPMC20099
OpenAlexW2019686213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.